Session » Healthcare Disparities in Rheumatology - Poster II

Date: Monday, November 14, 2016

Time: 9:00AM-11:00AM

Meeting: 2016 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 1249

“There Are Still a Lot of Things That I Need”: A Qualitative Study Exploring Opportunities to Improve the Health Outcomes of First Nations People with Arthritis Seen at an on-Reserve Outreach Rheumatology Clinic

9:00AM-11:00AM: Abstract Number: 1248

Access to Care: The Patient Perspective from the 2015 ACR/ARHP Workforce Study

9:00AM-11:00AM: Abstract Number: 1260

Association of Traditional Chinese Medicine Use and Adherence to Prescribed Western Medications in Chinese-American Rheumatology Patients

9:00AM-11:00AM: Abstract Number: 1247

Diagnostic Modeling of Rheumatoid Arthritis in Oklahoma Tribal Members Using Soluble Mediators

9:00AM-11:00AM: Abstract Number: 1256

Disparities in Total Knee Replacement: Population Losses in Quality-Adjusted Life Years Due to Differential Offer, Acceptance, and Complication Rates in African Americans

9:00AM-11:00AM: Abstract Number: 1251

Does Preconsult Electronic Exchange Affect Postconsult Diagnosis?

9:00AM-11:00AM: Abstract Number: 1253

Evaluation of a Pre-Assessment Tool to Define the Spectrum of Autoimmune Diseases in an Underserved Environment

9:00AM-11:00AM: Abstract Number: 1259

Factors Influencing Patient’s Participation in Rheumatology Research Studies: Experience from a Single Academic Centre

9:00AM-11:00AM: Abstract Number: 1258

Female Gender Is Associated with a Poorer Response to TNF-Inhibitors in Ankylosing Spondylitis

9:00AM-11:00AM: Abstract Number: 1257

Gender Differences in Ankylosing Spondylitis Patients Treated with Anti-TNF in Daily Practice with Ten Year Follow up

9:00AM-11:00AM: Abstract Number: 1254

Knee Pain and Patient Preference for Knee Replacement: Healthcare Access Matters

9:00AM-11:00AM: Abstract Number: 1255

Medicare Part B Utilization By Rheumatology Health Care Providers As Related to Population Demographics from 2013

9:00AM-11:00AM: Abstract Number: 1250

Mortality in Indigenous Populations of Canada, the United States, Australia, and New Zealand with Rheumatic Disease: A Systematic Review

9:00AM-11:00AM: Abstract Number: 1252

Socioeconomic Status and Not Race Associated with Delay in Diagnosis and Treatment of Rheumatoid Arthritis

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].